Venrock PIPEs Neurocrine Biosciences
Venrock has agreed to purchase $10 million worth of common stock in Neurocrine Biosciences Inc. (Nasdaq: NBIX), a San Diego-based drug company focused on neurological and endocrine diseases and disorders.
17 December 2009•2 mins read
